IPP Bureau
India’s pharma market to hit US$ 130 billion, exports US$ 80 billion by 2030: ASSOCHAM
By IPP Bureau - June 12, 2026
Knowledge paper highlights biosimilars, biologics, AI-driven drug discovery and regulatory excellence as key growth drivers for the next phase of India's pharma expansion
Biopharma SHAKTI envisages launch of 100 biologics by 2047: Anupriya Patel
By IPP Bureau - June 12, 2026
The union minister spoke at the 2nd Pharma Summit & Awards 2026 organised by ASSOCHAM in New Delhi
Major UK study to evaluate newborn screening for spinal muscular atrophy
By IPP Bureau - June 12, 2026
SENS study to assess feasibility, effectiveness and family experience of introducing SMA screening into the NHS newborn screening programme
Industry, regulators and quality experts discuss implementation of Indian Pharmacopoeia 2026
By IPP Bureau - June 12, 2026
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
Research must translate into real-world solutions: Dr. Jitendra Singh
By IPP Bureau - June 12, 2026
Union Minister inaugurated a DST-funded Central Instrumentation Facility and three new research clusters focused on advanced materials, clean energy, and healthcare at IIT Gandhinagar
Narayana Health achieves HIMSS AMAM Stage 6, first in Indian subcontinent
By IPP Bureau - June 12, 2026
Recognition highlights the hospital network’s decade-long investment in analytics and AI-driven healthcare, supporting improved outcomes, efficiency, and affordability.
MedGenome documentary highlights role of genomics in personalized cancer care
By IPP Bureau - June 12, 2026
The film tells the story of a 70-year-old woman from Kota, Rajasthan, whose persistent cough led to a diagnosis of advanced lung cancer
Parexel to showcase AI, real-world evidence and patient-centric innovations at DIA 2026
By IPP Bureau - June 12, 2026
Company experts to participate in eight sessions covering AI-powered clinical development, regulatory innovation, oncology research, and patient engagement
Symeres expands spray drying capabilities to accelerate small-molecule drug development in New Jersey
By IPP Bureau - June 11, 2026
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Evonik unveils probiotic advance in fight against antibiotic resistance
By IPP Bureau - June 11, 2026
Evonik researchers say they have achieved a significant breakthrough with Ecobiol
Dr. Mahesh N. Padamwar joins MSN Laboratories as Senior General Manager
By IPP Bureau - June 11, 2026
Pharmaceutical R&D veteran brings over 20 years of expertise in formulation development, ANDA filings, and regulated-market product innovation to strengthen MSN Laboratories’ global growth ambitions
Glenmark launches Winlevi across key European markets
By IPP Bureau - June 11, 2026
First-in-class topical androgen receptor inhibitor marks Glenmark’s first New Chemical Entity (NCE) launch in Europe
ASMS explores strategic research collaboration with Mediciti Institute
By IPP Bureau - June 11, 2026
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Cloudnine Hospitals launches one-year fellowship for obstetricians and gynaecologists
By IPP Bureau - June 11, 2026
Programme aims to strengthen fertility care expertise through advanced clinical training, mentorship and hands-on experience in reproductive medicine
Bayer’s asundexian moves into EU regulatory review as stroke prevention race intensifies
By IPP Bureau - June 11, 2026
The validation confirms the submission is complete, clearing the way for the EMA’s centralized review process to formally evaluate the therapy
